NIH UH2 funding opportunities: Exploratory/Developmental Cooperative Agreement Phase I
1 NIH notice for UH2 (Exploratory/Developmental Cooperative Agreement Phase I) is open. Deadlines, institutes and what NIH has funded under each notice.
- Open notices1
- Forecast0
- Projects funded under them3,106
Open NIH UH2 notices
Institutes that fund UH2 projects under these notices
| Institute or center | Projects |
|---|---|
| National Cancer Institute (NCI) | 483 |
| National Heart Lung and Blood Institute (NHLBI) | 346 |
| National Institute on Aging (NIA) | 293 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 273 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 249 |
| National Institute of General Medical Sciences (NIGMS) | 244 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 215 |
| National Institute of Mental Health (NIMH) | 165 |
| National Institute on Drug Abuse (NIDA) | 133 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 125 |
Closed UH2 notices
- PAR-25-074: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
- PAR-25-118: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- PAR-23-052: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- PAR-23-313: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
- PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- RFA-AG-23-020: Building Infrastructure for Precision Medicine Research on Minority Health and Disparities in Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (UH2/UH3 Clinical Trial Not Allowed)
- RFA-AI-22-020: Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
- RFA-CA-21-037: 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
- RFA-DE-22-005: Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed)
- RFA-AA-21-014: Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
- RFA-TR-21-015: Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)
Questions people ask
What is an NIH UH2?
UH2 is NIH's activity code for the Exploratory/Developmental Cooperative Agreement Phase I. Each notice sets its own budget limit, project length and due dates.
How many NIH UH2 funding opportunities are open?
1 notice is open on Grants.gov, as of the latest data.